| Old Articles: <Older 951-960 Newer> |
|---|
 |
Chemistry World
March 16, 2006
Michael Gross |
Plant Virus Fixed with Antennae Researchers have coupled a virus with redox-active molecules. Such particles could become useful in nanoelectronics, they claim.   |
Chemistry World
March 14, 2006
Jon Evans |
Previous Research Can be a Bad Influence on Molecular Biologists Molecular biologists could inadvertently be reporting false experimental results because they are being overly influenced by previous findings, report a team of bioinformaticians. |
Bio-IT World
March 2006 |
Bio-IT World Bio-IT 50 The 50 companies profiled here have driven and continue to drive the future of biomedical research and drug discovery: Accelrys... Affymetrix.. Apple... Becton Dickinson... BlueArc... 454 Life Sciences... etc. |
Bio-IT World
March 2006
Salamone & Davies |
Merck President Touts Technology Benefits Peter Kim, president of Merck Research Laboratories, says that small changes in the drug discovery and development process can yield significant benefits in bringing new drugs to market. |
Bio-IT World
March 2006 |
Special Show Preview: It's Showtime! Highlights of the upcoming fifth annual Bio IT World conference: Decoding the Genome... The Six-Figure Sequence... E-Clinical Futures... etc. |
Bio-IT World
March 2006
Mark D. Uehling |
Microdoses of Excitement With new federal backing, microdose studies can allow regulators to radically shorten preclinical programs. |
Bio-IT World
March 2006
Kevin Davies |
Clinical Data Launches Landmark Trial Clinical Data has launched a Phase III clinical trial for the depression drug vilazodone and will concurrently develop a diagnostic test. The study could prove to be a landmark event in pharmacogenomic medicine. |
Bio-IT World
March 2006
Robert M. Frederickson |
Integration, Robotics, and Automation The integration of instruments and technology is a key concept driving the development of advanced life-sciences laboratory automation. More sophisticated robotics are also increasingly being integrated into automated systems. |
Bio-IT World
March 2006 |
News Blast X Prize... Junk Discovery... Susceptibility... Resistance... |
Bio-IT World
March 2006
Salvatore Salamone |
Pfizer Digs Deeper in Mining Trial Data Besides using the information mined from past trials to help design new studies, examine new uses for a drug, or study ways to minimize risks, the data-mining efforts are also being applied to looking at how drugs on the market are being used. |
| <Older 951-960 Newer> Return to current articles. |
